Category: Drugs and Pharmaceuticals

freeNewsArticles Story Summary: TOKYO and LONDON, U.K., May 12 (SEND2PRESS NEWSWIRE) — Dr. Andree Bates, president of the New York and London-based pharmaceutical analytics company Eularis, will be delivering a presentation on how to tell if you are making the wrong marketing decision. The Pharmaceutical Marketing Excellence conference takes place in Tokyo, Japan.

freeNewsArticles Story Summary: SAN MARINO, Calif., April 21 (SEND2PRESS NEWSWIRE) — Epeius Biotechnologies Corporation announced today that Interim Analysis of an on-going Phase I/II study of Rexin-G for pancreatic cancer confirmed Rexin-G’s anti-tumor activity with no major toxicity in patients with metastatic chemotherapy-resistant pancreatic cancer.

freeNewsArticles Story Summary: FRESNO, Calif., April 15 (SEND2PRESS NEWSWIRE) — Chairman and CEO, Paul Willis stated, ‘Just like his previous career at a large agribusiness company, Dr. Mark E. Whitacre has risen fast at Cypress Systems, Inc, last month being named the company’s chief operating officer and president of operations.’ Now Cypress and Whitacre are…

freeNewsArticles Story Summary: FRESNO, Calif., March 25 (SEND2PRESS NEWSWIRE) — Cypress Systems, Inc., a Fresno CA based biotechnology company, announced that it has promoted Mark E. Whitacre, Ph.D. to become the company’s Chief Operating Officer (COO) and President of Operations. Dr. Whitacre joined the executive management team in December 2006 as President of Technology and…

freeNewsArticles Story Summary: SAN MARINO, Calif., March 25 (SEND2PRESS NEWSWIRE) — Epeius Biotechnologies Corporation announced today the issue of U.S. Patent No. 7,347,998 for Targeted Gene Delivery in vivo. This patent provides additional intellectual property protection for the platform of highly advanced biotechnologies embodied in the company’s leading anti-cancer agent, Rexin-G.

freeNewsArticles Story Summary: NEW YORK, N.Y. and LONDON, U.K., March 12 (SEND2PRESS NEWSWIRE) — Costing the global pharmaceutical industry an estimated $30 billion per year and causing an estimated 125,000 deaths per year in the United States, patient non-adherence is a looming issue in the healthcare industry. Eularis has responded to this problem with a…

freeNewsArticles Story Summary: SALT LAKE CITY, Utah, March 6 (SEND2PRESS NEWSWIRE) — The same diet that’s helping you lose weight might actually be causing you to retain figure-destroying belly fat. That ‘s because dieting is stressful. You worry about what to eat… when to eat… how much to eat. All that worry leads to ‘diet…

freeNewsArticles Story Summary: AUSTIN, Texas – Jan. 4 (SEND2PRESS NEWSWIRE) — deverus, Inc., the leader in background screening technology, recently announced a partnership with eScreen Inc., a company known for its innovative drug screening technology. After comparing different providers, deverus found that no one could match the selection and quality of products that eScreen had…

freeNewsArticles Story Summary: SAN MARINO, Calif. – Dec. 18 (SEND2PRESS NEWSWIRE) — Epeius Biotechnologies Corporation announced today their appreciation of the accomplishments of their contemporaries in 2007, a truly remarkable year in terms of biomedical research, scholarship, and gonzo journalism. It was a year in which a definitive meeting entitled ‘In Vivo Barriers to Gene…

freeNewsArticles Story Summary: SAN MARINO, Calif. – Dec. 17 (SEND2PRESS NEWSWIRE) — Epeius Biotechnologies Corporation announced today that the company has received a Certificate of Product Registration for Rexin-G(R) from the Philippine Bureau of Food and Drugs (BFAD), enabling the commercialization of its lead product as a safe and effective treatment for a broad spectrum…